These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 11515383)

  • 1. Medications for the treatment of Alzheimer's disease.
    Lampley-Dallas VT
    J Okla State Med Assoc; 2001 Aug; 94(8):347-9. PubMed ID: 11515383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease: new pharmacological perspectives.
    Palacios JM
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():67-8. PubMed ID: 8899698
    [No Abstract]   [Full Text] [Related]  

  • 3. [Alzheimer's disease. Foreword].
    Derquesné C
    Rev Prat; 1998 Nov; 48(17):1871-2. PubMed ID: 9882238
    [No Abstract]   [Full Text] [Related]  

  • 4. New therapeutic approaches to Alzheimer's disease.
    Schneider LS
    J Clin Psychiatry; 1996; 57 Suppl 14():30-6. PubMed ID: 9024334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease.
    Prescrire Int; 2003 Dec; 12(68):230-1. PubMed ID: 14986699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic approaches to cognitive deficits in Alzheimer's disease.
    Peskind ER
    J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic agents for Alzheimer's disease].
    Honma A
    Nihon Naika Gakkai Zasshi; 1998 Jan; 87(1):169-74. PubMed ID: 9513562
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease.
    Crismon ML
    Pharmacotherapy; 1998; 18(2 Pt 2):47-54; discussion 79-82. PubMed ID: 9543465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New drugs for Alzheimer's disease in Japan.
    Takeda M; Tanaka T; Okochi M
    Psychiatry Clin Neurosci; 2011 Aug; 65(5):399-404. PubMed ID: 21851448
    [No Abstract]   [Full Text] [Related]  

  • 10. New therapeutic approaches to cognitive impairment.
    Schneider LS
    J Clin Psychiatry; 1998; 59 Suppl 11():8-13. PubMed ID: 9731544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current treatments for Alzheimer's disease: cholinesterase inhibitors.
    Doody RS
    J Clin Psychiatry; 2003; 64 Suppl 9():11-7. PubMed ID: 12934969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of journal advertisements on prescribers of cholinesterase inhibitors.
    Sauer J; Howard R
    Int J Geriatr Psychiatry; 2002 Oct; 17(10):976-8. PubMed ID: 12325061
    [No Abstract]   [Full Text] [Related]  

  • 13. Galantamine: new preparation. The fourth cholinesterase inhibitor for Alzheimer's disease.
    Prescrire Int; 2001 Dec; 10(56):180-1. PubMed ID: 11824442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms of action of Alzheimer medications].
    Alhainen K
    Duodecim; 2003; 119(20):1959-66. PubMed ID: 14640001
    [No Abstract]   [Full Text] [Related]  

  • 15. Donepezil (Aricept) therapy for Alzheimer's disease.
    Geldmacher DS
    Compr Ther; 1997 Jul; 23(7):492-3. PubMed ID: 9262925
    [No Abstract]   [Full Text] [Related]  

  • 16. Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.
    Prasher VP
    Int J Geriatr Psychiatry; 2004 Jun; 19(6):509-15. PubMed ID: 15211527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multinational, randomised, 12-week, comparative study of donepezil and rivastigmine in patients with mild to moderate Alzheimer's disease.
    Wilkinson DG; Passmore AP; Bullock R; Hopker SW; Smith R; Potocnik FC; Maud CM; Engelbrecht I; Hock C; Ieni JR; Bahra RS
    Int J Clin Pract; 2002; 56(6):441-6. PubMed ID: 12166542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to cholinesterase inhibitors in patients with Alzheimer's disease.
    Blais L; Kettani FZ; Perreault S; Leroux JC; Forget A; Kergoat MJ
    J Am Geriatr Soc; 2009 Feb; 57(2):366-8. PubMed ID: 19207161
    [No Abstract]   [Full Text] [Related]  

  • 19. [Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko].
    Gasser US; Gasser T
    MMW Fortschr Med; 2001 Dec; 143(51-52):40-1. PubMed ID: 11824165
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug treatment for Alzheimer's disease.
    Tom T; Cummings JL
    West J Med; 1998 Apr; 168(4):264. PubMed ID: 9584667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.